Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicardipine for Cerebral Protection in Cardiac Surgery
NCT05586347Completed
- Sponsor
- Nanjing First Hospital
- Start
- Apr 2022
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of nicardipine in Post-operative cognitive dysfunction (POCD) (2 arms), sponsored by Nanjing First Hospital. Primary endpoint: Internal carotid artery blood flow. Started Apr 2022; status: completed.
02
Drugs
nicardipine
03
Conditions
Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT05586347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05586347.